News

TCL is co-lead counsel in an antitrust litigation against pharmaceutical manufacturer Pfizer that recently settled for $39 million. Plaintiffs, direct purchasers of the brand name prescription drug Effexor, allege that Pfizer and Teva Pharmaceuticals entered into a “pay for delay” agreement where Pfizer made large payments to Teva in exchange for Teva’s agreement to delay […]

TCL Settles Antitrust Litigation Against Pfizer Read More »

On Monday, November 27 2023, U.S. District Judge John H. Chun of the Western District of Washington appointed attorneys from TCL to serve as interim co-lead counsel and consolidated two proposed class actions that raise antitrust claims against Defendant Amazon. In his order, Judge Chun appointed attorneys from TCL, Wexler, Boley & Elgersma, LLP, Cotchett,

TCL to serve as interim co-lead counsel and consolidated two proposed class actions that raise antitrust claims against Defendant Amazon. Read More »